Literature DB >> 23621203

Interferon stimulated gene-ISG15 is a potential diagnostic biomarker in oral squamous cell carcinomas.

Rupesh Puthenparambil Laljee1, Sunil Muddaiah, Basavaraj Salagundi, Ponappa Muckatira Cariappa, Adarsh Surendran Indra, Venkataram Sanjay, Arvind Ramanathan.   

Abstract

BACKGROUND: Cancer diagnostic biomarkers have a wide range of applications that include early detection of oral precancerous lesions and oral squamous cell carcinomas, and assessing the metastatic status of lesions. The interferon stimulated ISG15 gene encodes an ubiquitin-like protein, which conjugates to stabilize activation status of associated proteins. Hence a deregulated expression of ISG15 may promote carcinogenesis. Indeed overexpression of ISG15 has been observed in several cancers and hence it has been proposed as a strong candidate cancer diagnostic biomarker. Given the emerging relationship between malignant transformation and ISG15, we sought to examine the expression pattern of this gene in tumor biopsies of oral squamous cell carcinoma (OSCC) tissues collected from Indian patients.
MATERIALS AND METHODS: Total RNA isolated from thirty oral squamous cell carcinoma tissue biopsy samples were subjected to semi-quantitative RT-PCR with ISG15 specific primers to elucidate the expression level.
RESULTS: Of the thirty oral squamous cell carcinomas that were analyzed, ISG15 expression was found in twenty four samples (80%). Twelve samples expressed low level of ISG15, six of them expressed moderately, while the rest of them expressed very high level of ISG15.
CONCLUSIONS: To the best of our knowledge, the results show for the first time an overexpression of ISG15 in up to 80% of oral squamous cell carcinoma tissues collected from Indian patients. Hence ISG15 may be explored for the possibility of use as a high confidence diagnostic biomarker in oral cancers.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23621203     DOI: 10.7314/apjcp.2013.14.2.1147

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  8 in total

1.  ISG15 as a novel prognostic biomarker for hepatitis B virus-related hepatocellular carcinoma.

Authors:  Xiaoxin Qiu; Yuan Hong; Darong Yang; Man Xia; Haizhen Zhu; Qinglong Li; Hailong Xie; Qunfeng Wu; Chen Liu; Chaohui Zuo
Journal:  Int J Clin Exp Med       Date:  2015-10-15

2.  Interferon-stimulated gene 15 accelerates replication fork progression inducing chromosomal breakage.

Authors:  Maria Chiara Raso; Nikola Djoric; Franziska Walser; Sandra Hess; Fabian Marc Schmid; Sibylle Burger; Klaus-Peter Knobeloch; Lorenza Penengo
Journal:  J Cell Biol       Date:  2020-08-03       Impact factor: 10.539

Review 3.  ISG15 and ISGylation in Human Diseases.

Authors:  Oygul Mirzalieva; Meredith Juncker; Joshua Schwartzenburg; Shyamal Desai
Journal:  Cells       Date:  2022-02-04       Impact factor: 7.666

4.  ISG15 as a prognostic biomarker in solitary fibrous tumour.

Authors:  Jose L Mondaza-Hernandez; David S Moura; María Lopez-Alvarez; Paloma Sanchez-Bustos; Elena Blanco-Alcaina; Carolina Castilla-Ramirez; Paola Collini; Jose Merino-Garcia; Jorge Zamora; Jaime Carrillo-Garcia; Roberta Maestro; Nadia Hindi; Jesus Garcia-Foncillas; Javier Martin-Broto
Journal:  Cell Mol Life Sci       Date:  2022-07-21       Impact factor: 9.207

Review 5.  ISG15 in the tumorigenesis and treatment of cancer: An emerging role in malignancies of the digestive system.

Authors:  Chaohui Zuo; Xinyi Sheng; Min Ma; Man Xia; Linda Ouyang
Journal:  Oncotarget       Date:  2016-11-08

6.  Inhibition of ISG15 Enhances the Anti-Cancer Effect of Trametinib in Colon Cancer Cells.

Authors:  Sheng Zhou; Meilin Ren; Huanji Xu; Hongwei Xia; Qiulin Tang; Ming Liu
Journal:  Onco Targets Ther       Date:  2019-11-26       Impact factor: 4.147

Review 7.  More than Meets the ISG15: Emerging Roles in the DNA Damage Response and Beyond.

Authors:  Zac Sandy; Isabelle Cristine da Costa; Christine K Schmidt
Journal:  Biomolecules       Date:  2020-11-15

8.  Expression of Ki-67, Cornulin and ISG15 in non-involved mucosal surgical margins as predictive markers for relapse in oral squamous cell carcinoma (OSCC).

Authors:  Padmanabha Kumar Govindaraj; Thomas George Kallarakkal; Rosnah Mohd Zain; Wanninayake Mudiyanselage Tilakaratne; Huai Lin Lew
Journal:  PLoS One       Date:  2021-12-23       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.